1294 Stock Overview
Hantech Bio-Technology Co., Ltd. manufactures and sells health supplement products in Taiwan.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Hantech Bio-Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$222.00 |
| 52 Week High | NT$301.00 |
| 52 Week Low | NT$54.17 |
| Beta | 0 |
| 1 Month Change | -2.84% |
| 3 Month Change | 85.77% |
| 1 Year Change | 298.91% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 506.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1294 | TW Personal Products | TW Market | |
|---|---|---|---|
| 7D | -3.1% | 0.2% | 4.0% |
| 1Y | 298.9% | -16.5% | 28.5% |
Return vs Industry: 1294 exceeded the TW Personal Products industry which returned -16.5% over the past year.
Return vs Market: 1294 exceeded the TW Market which returned 28.5% over the past year.
Price Volatility
| 1294 volatility | |
|---|---|
| 1294 Average Weekly Movement | 11.7% |
| Personal Products Industry Average Movement | 4.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in TW Market | 8.7% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 1294's share price has been volatile over the past 3 months.
Volatility Over Time: 1294's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | n/a | n/a | www.htbios.com |
Hantech Bio-Technology Co., Ltd. manufactures and sells health supplement products in Taiwan. It provides dietary supplements in gel, liquid, and powder forms under OEM or ODM partnerships. The company offers its dietary supplements in various packages, such as rectangle, curve, Z, round, wine bottle, and standing pouches.
Hantech Bio-Technology Co., Ltd. Fundamentals Summary
| 1294 fundamental statistics | |
|---|---|
| Market cap | NT$4.31b |
| Earnings (TTM) | NT$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 1294 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1294 income statement (TTM) | |
|---|---|
| Revenue | NT$0 |
| Cost of Revenue | NT$0 |
| Gross Profit | NT$0 |
| Other Expenses | NT$0 |
| Earnings | NT$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 1294 perform over the long term?
See historical performance and comparison